Lumexa Imaging (LMRI) Stock Insights

LMRI price $11.62 -0.05 -0.43%

Ticker
LMRI
Price
$11.62
Change
-0.05 -0.43%
Market cap ?
$1.12B
Beta ?
1.01
Sector
Healthcare
Industry
Medical - Devices

Fair value

LMRI fair value $17.13. Price $11.62. Price is 32% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 77.72M. Growth 4.27%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.87% (beta 1.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 96.07M. Net debt 903.68M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare LMRI

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—0.20—270.27M
2026-08-120.200.15264.16M263.12M
2026-05-120.180.12252.54M249.52M
2026-03-26-0.380.05267.73M261.17M
2025-12-03-0.030.05260.08M261.17M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-10Mittl Robert Louis Jr.Buy19.36K——
2026-06-10Lungren MatthewBuy19.36K——
2026-06-10Karlin Bridget EBuy19.36K——
2026-06-10Joseph MollyBuy19.36K——
2026-06-10EISENBERG GLENN ABuy19.36K——
2026-06-10Cooper Henry LeeBuy19.36K——
2026-06-10BRODNAX BRETTBuy19.36K——
2026-05-19BRODNAX BRETTBuy35.00K$7.25253.75K
2026-05-14Cooper Henry LeeBuy30.00K$7.44223.11K
2026-02-25Walker James Edward Jr.Buy12.41K——
2025-12-12Martin James AnthonyBuy27.03K——
2025-12-12Martin James AnthonyBuy27.03K——
2025-12-12Walker James Edward Jr.Buy4.93K——
2025-12-12Zulla CaitlinBuy64.86K——
2025-12-12Zulla CaitlinBuy64.86K——
2025-12-12BRODNAX BRETTBuy27.03K——
2025-12-12Joseph MollyBuy27.03K——
2025-12-12Stewart RussellBuy4.23K——
2025-12-12Stewart RussellBuy4.23K——
2025-12-12Szeker JulieBuy81.08K——
2025-12-12Szeker JulieBuy66.18K——
2025-12-12Szeker JulieSell1.25M——
2025-12-11Martin James AnthonyOther388.89K$18.507.19M
2025-12-11Walker James Edward Jr.Other55.55K$18.501.03M
2025-12-11Mittl Robert Louis Jr.Other91.26K——
2025-12-11Szeker JulieOther12.62K——
2025-12-11Szeker JulieOther63.89K$18.501.18M
2025-12-11Szeker JulieOther66.18K——
2025-12-11Stewart RussellOther194.44K$18.503.60M
2025-12-11Zulla CaitlinOther833.33K$18.5015.42M
2025-12-11Zulla CaitlinOther14.95K——
2025-12-11REGAN BRIAN THOMASOther0——
2025-12-11BRODNAX BRETTOther22.22K$18.50411.11K
2025-12-11Cooper Henry LeeOther422.22K$18.507.81M
2025-12-11EISENBERG GLENN AOther22.22K$18.50411.11K
2025-12-11Joseph MollyOther22.22K$18.50411.11K
2025-12-11Karlin Bridget EOther22.22K$18.50411.11K
2025-12-11Lungren MatthewOther22.22K$18.50411.11K
2025-12-11Welsh, Carson, Anderson & Stowe XII Cayman, L.P.Other49.01K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 104, holders +14 vs prior quarter. Ownership 32.95%.

HolderSharesChangeChange %Value
BROWN ADVISORY INC5.78M4.07M+238.85%65.17M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/3.45M1.12M+47.94%38.96M
THINK INVESTMENTS LP2.56M2.56MNew28.87M
JUPITER TOPCO LLC2.15M2.15MNew24.27M
BLACKROCK, INC.1.40M-127.57K-8.36%15.77M
JPMORGAN CHASE & CO1.15M49.96K+4.52%13.25M
VANGUARD CAPITAL MANAGEMENT LLC1.07M11.84K+1.12%12.07M
GOLDMAN SACHS GROUP INC807.43K41.92K+5.48%9.11M
ROYCE & ASSOCIATES LP789.04K459.04K+139.10%8.90M
SCHONFELD STRATEGIC ADVISORS LLC768.89K568.19K+283.10%8.67M
BRIGADE CAPITAL MANAGEMENT, LP665.90K665.90KNew7.51M
RTW INVESTMENTS, LP650.00K00.00%7.33M
MILLENNIUM MANAGEMENT LLC627.99K-86.69K-12.13%7.08M
GEODE CAPITAL MANAGEMENT, LLC626.32K-47.82K-7.09%7.07M
ADAGE CAPITAL PARTNERS GP, L.L.C.625.27K206.74K+49.40%7.05M
ARROWMARK COLORADO HOLDINGS LLC602.05K-1.05M-63.58%6.79M
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND600.00K-700.00K-53.85%6.77M
LONGAEVA PARTNERS L.P.528.80K-28.62K-5.13%5.96M
SILVERCREST ASSET MANAGEMENT GROUP LLC467.34K467.34KNew5.27M
STATE STREET CORP459.13K82.34K+21.85%5.18M
FRANKLIN TEMPLETON INC448.54K125.64K+38.91%5.06M
BULLSEYE ASSET MANAGEMENT LLC390.19K370.19K+1850.93%4.40M
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.357.05K00.00%4.03M
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC292.92K-12.66K-4.14%3.30M
POINT72 ASSET MANAGEMENT, L.P.280.96K179.69K+177.42%3.17M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Lumexa Imaging (LMRI) Stock Insights

LMRI$11.62-0.05 -0.43%

$1.12B

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History